Medicinal Genomics

NOVEMBER 12, 2024

As a result, labs that have received a state license to test either medical or recreational cannabis have historically been denied a DEA Schedule I license to test hemp under the 2018 Farm Bill. However, this may change with rescheduling that is going to be revisited on Dec 2, 2024.

Compliance 52

Compliance Compliance Data Agriculture 52

Canna Law Blog

JANUARY 8, 2025

cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. Key global cannabis law developments in 2024 Germany passed a quasi-legalization law with two phases. As the U.S.

Law 123

Law Programs Cultivation Hemp 123

Canna Law Blog

NOVEMBER 21, 2024

They’re calling it the Rural Prosperity and Food Security Act of 2024 (the “Senate bill”). The Senate bill follows on the House’s proposal, called the Farm, Food and National Security Act of 2024 (the “House bill”), offered in May. That could happen in 2024, but seems more likely in 2025 when the new Congress convenes.

Hemp 100

Hemp Seed-To-Sale DEA Sativa 100

The Cannigma

MAY 15, 2023

Schedule III substances are subject to certain controls not applicable to all other prescription drugs, including the requirement that a medical professional with a specific license issued by the Drug Enforcement Agency (DEA) must conduct an in-person examination before prescribing it. At-home ketamine treatment programs vary.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Cannabis Law Report

SEPTEMBER 12, 2022

Virginia 2024 adult use program may be postponed: [link]. DEA grants research license for psychedelics and major depression first human trial: [link]. Dallas County District Attorney discusses freeing up cops for 911 calls instead of 5 hours a piece on marijuana arrest paperwork: [link].

DEA 98

DEA Hemp Dispensary Therapy 98

The Blunt Truth

OCTOBER 3, 2019

And Michigan is expanding the number of communities eligible for its social equity program. In other judicial news, a judge in New Mexico ruled that the state must accept non-residents into its medical marijuana program. ” Since the CBD industry is projected to surpass $20 billion by 2024 , those tests might come in handy.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

The Blunt Truth

JANUARY 19, 2024

HHS DOCUMENT RELEASE Last month , the Department of Health and Human Services (HHS) released a heavily redacted version of their recommendation to the Drug Enforcement Administration (DEA) that cannabis be moved from Schedule I to Schedule III. Of course, the DEA will make its own decision, as we noted earlier this month.

DEA 59

DEA Retail Consumption Legalization 59

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Some states that have passed recreational or medical marijuana legislation are still negotiating the details for implementing these programs.

Recreational 52

Recreational Data Cannabis DEA 52

Canna Law Blog

MARCH 5, 2025

But there’s a group of players who’ve been surprisingly quiet, despite potentially having the most to gain: DEA-registered bulk marijuana manufacturers. However, under current US law, DEA Registrants are missing out on a massive opportunity. tons in Q4 of 2024 a fourfold increase from Q1. billion by 2027.

DEA 66

DEA Research and Development Marijuana Pharmaceutical 66

Canna Law Blog

MARCH 7, 2023

EB-5 program. The INA contains an immigrant investor program at 8 USC § 1153(b)(5) that allows foreign nationals to apply for permanent residence by making a minimum investment in a new commercial enterprise in the U.S. The program, known as “EB-5”, is much more complex but for or purposes here that will do. Bright Green Corp.,

DEA 91

DEA Research and Development Programs Cannabis 91

The Blunt Truth

DECEMBER 22, 2023

We note that New York’s cannabis licensing program is facing yet another lawsuit. UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. Look for more on this in 2024 also.

DEA 52

DEA Retail Programs Hemp 52

Canna Law Blog

AUGUST 14, 2023

At least not in Congress, and at least not before the 2024 general election. No state’s regulatory program will comply with federal laws if cannabis is on any CSA schedule. Just think about someone selling anabolic steroids with a state license but no DEA registration.

Law 98

Law Cannabis Data Business 98